Learn about the latest advances in diabetes and other endocrine disorders from the experts of the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at Mount Sinai. Our physician-scientists are on the leading edge of diabetes discoveries that have immediate impact on our patients. Andrew Stewart, MD, focuses his research on innovative therapies to regenerate insulin-producing pancreatic beta cells. Carol Levy, MD, directed the first clinical trials for the artificial pancreas. Division Chief Andrea Dunaif, MD, is a leading researcher in genes for polycystic ovary syndrome, a major cause of diabetes in women. We also have multidisciplinary centers of excellence in adrenal, pituitary, and thyroid disorders, as well as in weight management.
The Division of Endocrinology, Diabetes and Bone Disease at The Mount Sinai Hospital is nationally ranked by U.S. News & World Report® for 2024-25. The Division of Endocrinology, Diabetes and Bone Disease at Mount Sinai Morningside and Mount Sinai West is also nationally ranked by U.S. News & World Report® for 2024-25.
Learn about the latest advances in diabetes and other endocrine disorders from the experts of the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at Mount Sinai. Our physician-scientists are on the leading edge of diabetes discoveries that have immediate impact on our patients. Andrew Stewart, MD, focuses his research on innovative therapies to regenerate insulin-producing pancreatic beta cells. Carol Levy, MD, directed the first clinical trials for the artificial pancreas. Division Chief Andrea Dunaif, MD, is a leading researcher in genes for polycystic ovary syndrome, a major cause of diabetes in women. We also have multidisciplinary centers of excellence in adrenal, pituitary, and thyroid disorders, as well as in weight management.
The Division of Endocrinology, Diabetes and Bone Disease at The Mount Sinai Hospital is nationally ranked by U.S. News & World Report® for 2024-25. The Division of Endocrinology, Diabetes and Bone Disease at Mount Sinai Morningside and Mount Sinai West is also nationally ranked by U.S. News & World Report® for 2024-25.
Carol J. Levy, MD, and her team are working to expand the use of automated insulin delivery technology—studying its use in insulin-requiring people with type 2 diabetes and during pregnancies complicated by type 1 diabetes.
A team led by Andrea Dunaif, MD, has identified regions of DNA associated with testosterone production in women with polycystic ovary syndrome, bringing the field a step closer to determining the molecular causes of the condition.
The fellows are treating complex conditions in the large population that the Mount Sinai Health System serves, and working closely with renowned experts in the field.
The Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at the Icahn School of Medicine at Mount Sinai is dedicated to advancing the understanding and treatment of diabetes, obesity, conditions affecting ...
With the publication of two 2024 studies, the Mount Sinai team led by Terry F. Davies, MD, continued to expand understanding of the physiologic mechanisms of Graves’ disease, as well as of thyroid eye disease, which about a third of people ...
Two 2024 studies from Mount Sinai—one on the risk of venous thromboembolism in transgender people and the other on understanding the effects of estrogen dose and route of administration on serum levels—provide vital information and insights ...
A case review by a team at the Icahn School of Medicine at Mount Sinai highlighted the crucial role of endocrinologists in the assessment and management of patients with adrenocortical carcinoma, a rare and aggressive form of cancer.
Carol J. Levy, MD, and teams at the Mount Sinai Diabetes Center are working to broaden the reach of diabetes technology to more people who could benefit from it, including pregnant women with type 1 diabetes and people with type 2 diabetes ...
While much is known about how organs such as the liver, fat tissue, and pancreas contribute to metabolic diseases, a Mount Sinai researcher and his team have turned their focus to a novel subject—the mammary gland.
Inaccuracies in laboratory testosterone testing have long hindered appropriate management in several patient groups, including women with polycystic ovary syndrome and men with suspected low testosterone.
The Institute made further outstanding progress in the study of diabetes, obesity, and metabolic syndromes under the leadership of the Institute Director, Andrew F. Stewart, MD.
Mount Sinai researchers examined the significance of prediabetes prior to conception among adolescents and young adults, a group that is most at risk of unplanned pregnancy. The findings could alter how doctors routinely screen or counsel ...
A new Mount Sinai program takes a holistic, multidisciplinary approach to managing obstructive sleep apnea (OSA) among patients with obesity. It is a timely undertaking, not only because the prevalence of obesity is rising in the United ...
Mount Sinai researchers have demonstrated that a two-drug combination to enable the regeneration of insulin-producing pancreatic beta cells for people with diabetes. One of the drugs, harmine, is a natural product found in plants.
A team from the Icahn School of Medicine at Mount Sinai has developed the most comprehensive epidemiological dataset for youth diabetes and prediabetes research, derived from extensive National Health and Nutrition Examination Survey (NHANES) ...
The Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at the Icahn School of Medicine at Mount Sinai is dedicated to advancing the understanding and treatment of diabetes, obesity, conditions affecting ...
The outstanding faculty in the Division of Endocrinology, Diabetes and Bone Disease continue to make innovative advances in translational research and clinical care. Core to those missions is training the next generation of leaders in our field.
The merger of Mount Sinai’s Endocrinology fellowships into a systemwide, five-hospital program has proved successful in its first two years, with the 14 fellows gaining a wide variety of experience in research and clinical care.
The Diabetes, Obesity and Metabolism Institute made further outstanding progress in 2023 in the study of diabetes, obesity, and metabolic syndromes. The Institute continued its pioneering research in beta cell regeneration and a rising ...
The increasing use of biologic agents for chronic treatment of Crohn’s disease and ulcerative colitis has meant that corticosteroids are typically reserved for use during flares. The intermittent use of these efficacious therapies has ...
A team led by Prashant Rajbhandari, PhD, discovered a family of molecules in the breast called “mammokines” that contribute not only to normal mammary biology, but to overall fat cell physiology and energy balance control.
Patients with multiple myeloma who also have diabetes have reduced overall survival when compared to those without diabetes. However, in a subgroup analysis, this difference in survival due to diabetes was seen in white patients but not in Black patients.
Testosterone treatment for gender-affirming hormone therapy in transmasculine individuals often conjures up safety concerns among prescribing physicians, and patients and their families. However, the largest study of its type to date found ...
Mount Sinai researchers have made breakthrough discoveries about the thyroid-stimulating hormone receptor that suggest new approaches to the treatment of autoimmune thyroid disease.
People who develop diabetes following pregnancy were significantly less likely to be able to bring it under control if they had experienced gestational diabetes mellitus during their pregnancy, especially if they were Black or Hispanic.
